(Sonya Yruel/Drug Policy Alliance) Paul Armentano | October 20, 2017 Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. Non-alcoholic fatty liver disease is the most prevalent form of liver disease, affecting …
Hawaii Licenses 2nd Testing Lab
Hawaii’s second medical cannabis testing lab has been licensed and can begin testing products immediately, according to a KITV report. Pharmlab Hawaii is expected to test products for dispensaries on Maui; Steep Hill Hawaii, located in Oahu, was approved to test products in July and until now have been the sole testing facility in the state. Wanda Change, Department of …
Peru Legalizes Medical Cannabis
Peru’s Congress has legalized cannabis for medical use in a 67-5 vote with three abstaining, according to a report from Al Día News. The measure legalizes cannabis and its derivatives as a cancer, epilepsy, and Parkinson’s disease therapy. Congressman Alberto de Belaunde, who championed the legislation called the bill’s passage a “historic moment” for the nation’s Congress. Once the bill …
Michigan Gov. Appoints 7 to MMJ Advisory Panel
Michigan Gov. Rick Snyder has appointed seven members to the state’s Marihuana Advisory Panel, including representatives for law enforcement, physicians, patients, counties, and towns. Snyder is also tasked with appointing another five members to the panel representing cultivators, processors, dispensaries, and safety compliance facilities but according to the governor’s office, those appointments will wait until after the new medical cannabis …
Jamaica Licenses First MMJ Cultivator & Producer
Jamaica’s Cannabis Licensing Authority has granted its first approvals for the nation’s medical cannabis industry, as Everything Oily Labs Limited was issued a processing license and Epican was issued a license to cultivate, the Jamaica Gleaner reports. Hyacinth Lightborne, chair of the CLA, indicated that three other applications were also approved and those companies were “completing their requirements,” while another 57 …
Quality Assurance In The Field: Instruments For Growers & Processors
As the cannabis marketplace evolves, so does the technology. Cultivators are scaling up their production and commercial-scale operations are focusing more on quality. That greater attention to detail is leading growers, extractors and infused product manufacturers to use analytical chemistry as a quality control tool. Previously, using analytical instrumentation, like mass spectrometry (MS) or gas chromatography (GC), required experience in …
Sessions: ‘Healthy’ for Feds to Approve More Cannabis Research Applications
During a Senate Judiciary Committee oversight hearing, Attorney General Jeff Sessions admitted that it would “be healthy to have some more competition” in the federal government’s cannabis research program, noting that there are currently 26 supplier applications before the Drug Enforcement Agency from entities interested in growing cannabis for federal medicinal research. “Each one of those [cultivation sites] has to …
Pennsylvania Allows First MMJ Producer to Begin Production
Cresco Yeltrah has been given the greenlight by the Pennsylvania Department of Health to begin medical cannabis production – it is the first licensed operator to receive the go-ahead in the state. The firm, one of 12 licensed in Pennsylvania, is based in Jefferson County, northeast of Pittsburgh. Cresco has already integrated with the state’s seed-to-sale tracking system and is …
What Is Going On With Germany’s Cannabis Bid?
Germany is proceeding down the path to officially grow its own medical cannabis crops. Medical use became legal this year, along with a federal mandate for cheap access. That means that public health insurance companies, which cover 90% of Germans, are now firmly on the hook if not front line of the cannabis efficacy issue. As such, Germany’s medical market …
Study: Opioid-Related Deaths Decrease after Colorado Legalization
According to a study published in the American Journal of Public Health, cannabis legalization in Colorado has led to a 6.5 percent decrease in opioid-related deaths, equaling .7 percent decrease in opioid deaths per month. “This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado,” the authors wrote concluded in the study titled “Recreational Cannabis Legalization …










